1. GENITAL PAPILLOMAVIRUS INFECTION
- Author
-
Jessica L. Severson, Stephen K. Tyring, and Karl R. Beutner
- Subjects
Cervical cancer ,Pathology ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,virus diseases ,Cancer ,Immunotherapy ,medicine.disease ,Asymptomatic ,Genital warts ,medicine ,Sex organ ,medicine.symptom ,business ,Ascus ,Subclinical infection - Abstract
Most genital human papillomavirus (HPV) infections are benign. Subclinical genital infections with HPV are extremely common. Genital HPV infections cause a spectrum of diseases, ranging from asymptomatic infection to invasive cervical cancer. The HPV types are divided into low- and high-risk viruses, based on their association with cervical cancer. When the low-risk HPV infections are clinically expressed, they produce external genital warts. Once clinically apparent, they may persist, spread, grow, spontaneously regress, and/or recur. The high-risk HPV types cause abnormal Pap smears, low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), atypical squamous cells of uncertain significance (ASCUS), and atypical glandular cells of uncertain significance (AGUS). When the high-risk HPV types are clinically recognized on the external genital area, they cause formation of papular lesions. A useful strategy for HPV control is immunotherapy. Adoptive cellular transfers involve collection of the cells involved in host defenses from patients with cervical cancer; then growing these cells; activating them ex vivo by cytokines, such as the recombinant IL-2; and transferring them back to the cancer patient as therapy.
- Published
- 2000